The concept and mechanisms of castration-resistant prostate cancer

Seiji Naito, masaki shiota

Research output: Contribution to journalReview article

Abstract

Castration-resistant prostate cancer (CRPC) is the term which has recently been raised instead of androgen-independent or hormone-refractory prostate cancer. CRPC is defined as the status of disease progression despite the serum testosterone level of castration (< 50 ng/mL), which can be caused by various mechanisms including androgen receptor (AR)-dependent and AR-independent pathways. Recent researches have revealed that aberrant activation of AR signaling due to ectopic androgen synthesis, AR amplification, AR overexpression, AR mutation, AR variant, AR cofactor, and AR post-translational modification is a key mechanism of CRPC. In addition, AR-independent pathway can contribute to the emergence of CRPC. Taken together, it has been thought that these various mechanisms heterogeneously make androgen-dependent to castration resistant in a spatiotemporal-specific manner.

Original languageEnglish
Pages (from-to)2090-2094
Number of pages5
JournalNihon rinsho. Japanese journal of clinical medicine
Volume72
Issue number12
Publication statusPublished - Dec 1 2014

Fingerprint

Castration
Androgen Receptors
Prostatic Neoplasms
Androgens
Post Translational Protein Processing
Disease Progression
Testosterone
Hormones
Mutation

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

The concept and mechanisms of castration-resistant prostate cancer. / Naito, Seiji; shiota, masaki.

In: Nihon rinsho. Japanese journal of clinical medicine, Vol. 72, No. 12, 01.12.2014, p. 2090-2094.

Research output: Contribution to journalReview article

@article{62098bdb29d345cfa2f788e46bdab8a5,
title = "The concept and mechanisms of castration-resistant prostate cancer",
abstract = "Castration-resistant prostate cancer (CRPC) is the term which has recently been raised instead of androgen-independent or hormone-refractory prostate cancer. CRPC is defined as the status of disease progression despite the serum testosterone level of castration (< 50 ng/mL), which can be caused by various mechanisms including androgen receptor (AR)-dependent and AR-independent pathways. Recent researches have revealed that aberrant activation of AR signaling due to ectopic androgen synthesis, AR amplification, AR overexpression, AR mutation, AR variant, AR cofactor, and AR post-translational modification is a key mechanism of CRPC. In addition, AR-independent pathway can contribute to the emergence of CRPC. Taken together, it has been thought that these various mechanisms heterogeneously make androgen-dependent to castration resistant in a spatiotemporal-specific manner.",
author = "Seiji Naito and masaki shiota",
year = "2014",
month = "12",
day = "1",
language = "English",
volume = "72",
pages = "2090--2094",
journal = "Astrophysical Journal",
issn = "0004-637X",
publisher = "IOP Publishing Ltd.",
number = "12",

}

TY - JOUR

T1 - The concept and mechanisms of castration-resistant prostate cancer

AU - Naito, Seiji

AU - shiota, masaki

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Castration-resistant prostate cancer (CRPC) is the term which has recently been raised instead of androgen-independent or hormone-refractory prostate cancer. CRPC is defined as the status of disease progression despite the serum testosterone level of castration (< 50 ng/mL), which can be caused by various mechanisms including androgen receptor (AR)-dependent and AR-independent pathways. Recent researches have revealed that aberrant activation of AR signaling due to ectopic androgen synthesis, AR amplification, AR overexpression, AR mutation, AR variant, AR cofactor, and AR post-translational modification is a key mechanism of CRPC. In addition, AR-independent pathway can contribute to the emergence of CRPC. Taken together, it has been thought that these various mechanisms heterogeneously make androgen-dependent to castration resistant in a spatiotemporal-specific manner.

AB - Castration-resistant prostate cancer (CRPC) is the term which has recently been raised instead of androgen-independent or hormone-refractory prostate cancer. CRPC is defined as the status of disease progression despite the serum testosterone level of castration (< 50 ng/mL), which can be caused by various mechanisms including androgen receptor (AR)-dependent and AR-independent pathways. Recent researches have revealed that aberrant activation of AR signaling due to ectopic androgen synthesis, AR amplification, AR overexpression, AR mutation, AR variant, AR cofactor, and AR post-translational modification is a key mechanism of CRPC. In addition, AR-independent pathway can contribute to the emergence of CRPC. Taken together, it has been thought that these various mechanisms heterogeneously make androgen-dependent to castration resistant in a spatiotemporal-specific manner.

UR - http://www.scopus.com/inward/record.url?scp=84965187345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84965187345&partnerID=8YFLogxK

M3 - Review article

C2 - 25518339

AN - SCOPUS:84965187345

VL - 72

SP - 2090

EP - 2094

JO - Astrophysical Journal

JF - Astrophysical Journal

SN - 0004-637X

IS - 12

ER -